Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Knowing when to start using a financial advisor is key to successful financial management. Invest in your future today.
20,304 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
Ripple faces a pivotal week as XRP tests critical support near $1 and resistance at $1.40. Analysts publish ripple (x...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...
Asana's 2026 earnings outlook blends strong ARR growth with improving efficiency. This guide breaks down the key numb...
Midweek markets staged a notable reversal as Nasdaq-led tech names helped spark a Wednesday comeback. This guide expl...
Kettle Hill Capital Management disclosed a new stake in RH, loading about 161,122 shares worth roughly $28.9 million....
Dutch Bros is pursuing aggressive growth inside its existing markets, aiming to dramatically increase store counts an...
When a cybersecurity giant bets $25 billion on a single platform, investors should understand the why, the potential ...
On March 12, investors navigated a mixed session in stock market today, march as a multi-day rally cooled. Hims And H...
Ohio is poised to boost its innovation engine. By conforming to the federal R&E immediate cost recovery rules, oh...